The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship
MA Duggan, WF Anderson, S Altekruse… - The American journal …, 2016 - journals.lww.com
Abstract The Surveillance, Epidemiology, and End Results (SEER) program of the National
Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately …
Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately …
Prostate cancer in men of African origin
KF McGinley, KJ Tay, JW Moul - Nature Reviews Urology, 2016 - nature.com
Men of African origin are disproportionately affected by prostate cancer: prostate cancer
incidence is highest among men of African origin in the USA, prostate cancer mortality is …
incidence is highest among men of African origin in the USA, prostate cancer mortality is …
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …
risk stratification and workup, treatment options for localized disease, and management of …
An RNA-based digital circulating tumor cell signature is predictive of drug response and early dissemination in prostate cancer
Blood-based biomarkers are critical in metastatic prostate cancer, where characteristic bone
metastases are not readily sampled, and they may enable risk stratification in localized …
metastases are not readily sampled, and they may enable risk stratification in localized …
Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies
BACKGROUND Prostate cancer (PCa) diagnosis is challenging because efforts for effective,
timely treatment of men with significant cancer typically result in over‐diagnosis and repeat …
timely treatment of men with significant cancer typically result in over‐diagnosis and repeat …
Low-risk prostate cancer: identification, management, and outcomes
Context The incidence of low-risk prostate cancer (PCa) has increased as a consequence of
prostate-specific antigen testing. Objective In this collaborative review article, we examine …
prostate-specific antigen testing. Objective In this collaborative review article, we examine …
Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3+ 4= 7 prostate cancer at transrectal ultrasound (TRUS)-guided …
Selected patients with transrectal ultrasound (TRUS)-guided biopsies containing Gleason
score 3+ 4= 7 prostate cancer (PCa) may be considered candidates for active surveillance …
score 3+ 4= 7 prostate cancer (PCa) may be considered candidates for active surveillance …
Secondary data sources for health services research in urologic oncology
Background Though secondary data analyses of large datasets may reduce logistical and
financial barriers required to perform significant and innovative work, such research requires …
financial barriers required to perform significant and innovative work, such research requires …
On the road to accurate protein biomarkers in prostate cancer diagnosis and prognosis: current status and future advances
Prostate cancer (PC) is a leading cause of morbidity and mortality among men worldwide.
Molecular biomarkers work in conjunction with existing clinicopathologic tools to help …
Molecular biomarkers work in conjunction with existing clinicopathologic tools to help …
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
Active surveillance (AS) is currently a widely accepted treatment option for men with
clinically localized prostate cancer (PCa). Several reports have highlighted the association …
clinically localized prostate cancer (PCa). Several reports have highlighted the association …